Tag: Over-the-Counter Drugs and Devices

Displaying 1 - 20 of 61 results.

Pages

The operators of a deceptive negative option scheme have agreed to a court-ordered preliminary injunction temporarily barring them from a wide range of conduct. The preliminary injunction stops the defendants from misleading consumers about supposedly “free trial” offers, enrolling them in unwanted...
In September 2019, the operators of a deceptive negative option scheme agreed to a court-ordered preliminary injunction temporarily barring them from a wide range of conduct.  The preliminary injunction stops the defendants from misleading consumers about supposedly “free trial”...
The Federal Trade Commission is mailing 2,897 checks totaling more than $113,000 to fully refund consumers who bought FlexiPrin, a deceptively marketed joint pain supplement. The average check amount is $39.18.
Chemical Free Solutions LLC (CFS), the seller of Cedarcide Original, a line of cedar oil-based products deceptively marketed as effective at stopping and preventing bed bug infestations, has settled Federal Trade Commission charges that it violated a 2013 order barring it from making scientifically...
The Federal Trade Commission and the Maine Office of the Attorney General today announced a complaint and three settlements with dietary supplement marketers who allegedly used radio infomercials deceptively formatted as talk shows and print ads featuring fictitious endorsers to advertise...
The Federal Trade Commission today announced a new “Enforcement Policy Statement on Marketing Claims for Over-the-Counter (OTC) Homeopathic Drugs.” The policy statement was informed by an FTC workshop held last year to examine how such drugs are marketed to consumers.
According to the FTC’s complaint, between June 2013 and October 2015 the defendants marketed and sold the “Doctor Trusted” seal and certification program to websites that primarily offered health-related products and services, such as dietary supplements.
CORRECTED The quote in this release has been updated for clarification. Viatek Consumer Products Group, Inc. and company owner and President Lou Lentine have agreed to settle Federal Trade Commission charges that they made deceptive claims for Viatek-brand Mosquito Shield Bands. The Commission...
Brief of the Federal Trade Commission urging the Third Circuit to reverse the district court’s summary judgment ruling, which held (1) that a brand-name drug manufacturer lacked monopoly power and (2) that product hopping almost never constitutes exclusionary conduct in any event. The...
The staff of the Federal Trade Commission has recommended that the U.S. Food and Drug Administration reconsider the framework it uses to regulate homeopathic medications because it may appear to conflict with the FTC’s advertising substantiation doctrine in ways that could harm consumers and cause...

Pages